Group One Trading
BNTX icon

Group One Trading’s BioNTech BNTX Stock Holding History

Group One Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Sell
21,540
-82,408
-79% -$7.76M ﹤0.01% 2215
2026
Q1 		$9.24M Buy
103,948
+101,522
+4,185% +$10.4M 0.02% 890
2025
Q4 		$231K Sell
2,426
-54,604
-96% -$5.5M ﹤0.01% 4246
2025
Q3 		$5.62M Sell
57,030
-16,547
-22% -$1.77M 0.01% 1381
2025
Q2 		$7.83M Buy
73,577
+10,273
+16% +$1.04M 0.02% 989
2025
Q1 		$5.76M Sell
63,304
-2,768
-4% -$310K 0.02% 963
2024
Q4 		$7.53M Buy
66,072
+50,615
+327% +$5.78M 0.02% 868
2024
Q3 		$1.84M Sell
15,457
-37,834
-71% -$3.48M 0.01% 1776
2024
Q2 		$4.28M Buy
53,291
+6,272
+13% +$573K 0.02% 902
2024
Q1 		$4.34M Sell
47,019
-4,946
-10% -$474K 0.02% 920
2023
Q4 		$5.48M Sell
51,965
-21,615
-29% -$2.18M 0.01% 1059
2023
Q3 		$7.99M Buy
73,580
+43,770
+147% +$4.84M 0.03% 641
2023
Q2 		$3.22M Buy
29,810
+742
+3% +$83.5K 0.01% 1313
2023
Q1 		$3.62M Sell
29,068
-20,547
-41% -$2.82M 0.01% 1052
2022
Q4 		$7.45M Sell
49,615
-371
-0.7% -$57.1K 0.02% 905
2022
Q3 		$6.74M Sell
49,986
-45,789
-48% -$7M 0.01% 956
2022
Q2 		$14.3M Sell
95,775
-111,243
-54% -$17M 0.02% 641
2022
Q1 		$35.3M Buy
207,018
+59,384
+40% +$9.98M 0.04% 369
2021
Q4 		$38.1M Buy
147,634
+53,992
+58% +$14.8M 0.03% 387
2021
Q3 		$25.6M Buy
93,642
+28,651
+44% +$9.11M 0.03% 511
2021
Q2 		$14.6M Sell
64,991
-4,344
-6% -$819K 0.02% 818
2021
Q1 		$7.57M Buy
69,335
+51,874
+297% +$5.51M 0.01% 1161
2020
Q4 		$1.42M Buy
17,461
+12,549
+255% +$1.23M ﹤0.01% 2322
2020
Q3 		$340K Sell
4,912
-3,825
-44% -$274K ﹤0.01% 3202
2020
Q2 		$583K Buy
+8,737
New +$436K ﹤0.01% 2505

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Group One Trading's BNTX Position: Q2 2026 in Review

Group One Trading reduced its BioNTech (BNTX) stake by 79% in Q2 2026, selling an estimated $7.76M and leaving 21,540 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

Group One Trading first reported a position in BNTX in Q2 2020 and has held it in 25 quarters since. The position peaked at $38.1M in Q4 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Group One Trading held 21,540 shares of BioNTech worth $2M as of Q2 2026.
  • Group One Trading sold 82,408 BioNTech shares in Q2 2026, an estimated $7.76M.
  • BioNTech made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2215 holding.
  • Group One Trading first reported a position in BioNTech in Q2 2020 and has held it in 25 quarters since.
  • Group One Trading's BioNTech position peaked at $38.1M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.